INNOVITAL SYSTEMS INC — Department of Defense SBIR Phase II: DHA SBIR SEQUENTIAL MEDICAL RESEARCH AND DEVELOPMENT PHASE II CONTRACT TITLED: AGITUBE (NO
INNOVITAL SYSTEMS INC — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,300,000 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Innovital Systems Inc won a $1.3 million DoD Phase II SBIR award to continue refining a medical device for clearing blood and fluid from the chest cavity. The work focuses on improving treatment of hemothorax and similar pleural conditions in military medical settings.
- Amount
- $1,300,000
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- MD
- Period
- 2024-01-05 → 2027-05-04
Technology domains
Description
DHA SBIR SEQUENTIAL MEDICAL RESEARCH AND DEVELOPMENT PHASE II CONTRACT TITLED: AGITUBE (NOW CLR),"FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS" PLEASE NOTE CLR IS NOT AN ABBREVIATION.